These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 11848020

  • 1. [Stromal leydig cell tumor coexisting with ascites].
    Czupkałło G, Jakowicki JA, Baranowski W.
    Ginekol Pol; 2001 Oct; 72(10):825-8. PubMed ID: 11848020
    [Abstract] [Full Text] [Related]

  • 2. [Virilizing ovarian tumor: a rare cause of androgenetic alopecia].
    Bahloul E, Amouri M, Masmoudi A, Chaabene K, Mnif F, Makni S, Amouri H, Abid M, Boudawara T, Turki H.
    Ann Dermatol Venereol; 2015 Apr; 142(4):303-4. PubMed ID: 25813185
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G, Manci N, Angeletti G, Celleno R, Fratini D, Gilardi G.
    Gynecol Obstet Invest; 1997 Apr; 44(2):141-4. PubMed ID: 9286731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A case of Leydig cell virilizing tumor of the ovary].
    Simonetti C, Di Vagno G, Cazzolla A, Melilli G, Di Gesú G, Cormio G, Selvaggi L.
    Minerva Ginecol; 1998 Dec; 50(12):545-7. PubMed ID: 10069169
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Virilizing ovarian tumors in the menopausal patient].
    Nadeau C, Gibelin H, Breheret J, Fieuzal S, Lefort G, Kraimps JL.
    J Chir (Paris); 2008 Dec; 145(5):493-5. PubMed ID: 19106875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
    Persechini ML, Motton S, Leguevaque P, Donadille F, Escourrou G, Vierasu B, Hamdi S, Bennet A, Caron P.
    Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.
    Faria AM, Perez RV, Marcondes JA, Freire DS, Blasbalg R, Soares J, Simões K, Hayashida SA, Pereira MA.
    Nat Rev Endocrinol; 2011 Apr; 7(4):240-5. PubMed ID: 21321567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV, Loughlin J, Shapiro SS.
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [Abstract] [Full Text] [Related]

  • 19. Leydig cell tumor in the post-menopausal woman: case report and literature review.
    Sherf S, Martinez D.
    Acta Biomed; 2016 Jan 16; 87(3):310-313. PubMed ID: 28112699
    [Abstract] [Full Text] [Related]

  • 20. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
    Souto SB, Baptista PV, Braga DC, Carvalho D.
    Arq Bras Endocrinol Metabol; 2014 Feb 16; 58(1):68-75. PubMed ID: 24728167
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.